Leland Gershell
Stock Analyst at Oppenheimer
(3.83)
# 1,948
Out of 5,044 analysts
725
Total ratings
38.3%
Success rate
4.7%
Average return
Main Sectors:
Stocks Rated by Leland Gershell
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CGEN Compugen | Reiterated: Buy | $4 | $2.13 | +87.79% | 4 | Oct 6, 2026 | |
| OCGN Ocugen | Reiterated: Buy | $10 | $0.9555 | +946.57% | 3 | Sep 29, 2026 | |
| LXEO Lexeo Therapeutics | Reiterated: Buy | $20 | $3.23 | +519.20% | 4 | Sep 23, 2026 | |
| ASND Ascendis Pharma | Reiterated: Buy | $262 → $312 | $229.23 | +36.11% | 38 | Sep 2, 2026 | |
| CAPR Capricor Therapeutics | Upgraded: Buy | $54 | $7.83 | +589.66% | 28 | Aug 25, 2026 | |
| SPRB Spruce Biosciences | Reiterated: Buy | $230 | $44.05 | +422.13% | 6 | Aug 25, 2026 | |
| ARGX argenx SE | Reiterated: Buy | $1,037 → $1,100 | $825.03 | +33.33% | 19 | Aug 18, 2026 | |
| EQ Equillium | Rated: Buy | $7 | $1.41 | +396.45% | 4 | Aug 14, 2026 | |
| OKUR OnKure Therapeutics | Reiterated: Buy | $30 → $14 | $2.41 | +480.91% | 3 | Aug 14, 2026 | |
| PALI Palisade Bio | Reiterated: Buy | $8 | $1.54 | +419.48% | 2 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $98 → $97 | $54.80 | +77.02% | 39 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $18 | $11.00 | +63.64% | 6 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $54 | $30.47 | +77.22% | 9 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $326 | $301.81 | +8.01% | 4 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $24 → $25 | $13.19 | +89.54% | 18 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $50 → $60 | $36.83 | +62.91% | 48 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.73 | - | 8 | Jun 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $3.77 | - | 2 | Jun 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14 | $2.98 | +369.80% | 7 | Jun 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 → $28 | $2.76 | +916.33% | 21 | May 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $1.27 | +687.40% | 16 | May 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $18.66 | - | 34 | Apr 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $35 → $21 | $4.76 | +341.18% | 2 | Feb 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 | $2.46 | +916.26% | 44 | Feb 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $27.66 | - | 7 | Feb 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $2,000 | $31.73 | +6,203.18% | 4 | Nov 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $18 | $10.48 | +71.76% | 11 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $90.78 | - | 6 | Nov 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $35 | $13.65 | n/a | 28 | Sep 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $80 | $23.33 | n/a | 1 | Sep 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $490 | $232.68 | n/a | 42 | Aug 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 | $1.10 | n/a | 20 | Sep 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $106 | $62.91 | n/a | 3 | May 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $1.38 | n/a | 19 | Mar 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $2.91 | n/a | 17 | Dec 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $11 | $0.765 | n/a | 19 | Nov 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $2.08 | n/a | 16 | Jul 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $3.86 | n/a | 6 | Oct 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $60 | $0.11 | n/a | 11 | May 26, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $70 → $200 | $0.000001 | n/a | 11 | Mar 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $5.38 | n/a | 16 | Nov 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $8 | $0.001 | n/a | 1 | Jun 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $12 | $0.4298 | n/a | 11 | Jun 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $7 | $1.14 | n/a | 16 | May 18, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $42 | $1.38 | n/a | 7 | May 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $0.012 | n/a | 4 | May 6, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $10.36 | n/a | 22 | Dec 31, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $12.03 | n/a | 13 | Dec 31, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.5989 | n/a | 9 | Dec 31, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.0079 | n/a | 15 | Sep 11, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 | $1.27 | n/a | 3 | May 10, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.08 | n/a | 9 | May 9, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 | $4.97 | n/a | 9 | Apr 3, 2019 |
Compugen
Oct 6, 2026
Reiterated: Buy
Price Target: $4
Current: $2.13
Upside: +87.79%
Ocugen
Sep 29, 2026
Reiterated: Buy
Price Target: $10
Current: $0.9555
Upside: +946.57%
Lexeo Therapeutics
Sep 23, 2026
Reiterated: Buy
Price Target: $20
Current: $3.23
Upside: +519.20%
Ascendis Pharma
Sep 2, 2026
Reiterated: Buy
Price Target: $262 → $312
Current: $229.23
Upside: +36.11%
Capricor Therapeutics
Aug 25, 2026
Upgraded: Buy
Price Target: $54
Current: $7.83
Upside: +589.66%
Spruce Biosciences
Aug 25, 2026
Reiterated: Buy
Price Target: $230
Current: $44.05
Upside: +422.13%
argenx SE
Aug 18, 2026
Reiterated: Buy
Price Target: $1,037 → $1,100
Current: $825.03
Upside: +33.33%
Equillium
Aug 14, 2026
Rated: Buy
Price Target: $7
Current: $1.41
Upside: +396.45%
OnKure Therapeutics
Aug 14, 2026
Reiterated: Buy
Price Target: $30 → $14
Current: $2.41
Upside: +480.91%
Palisade Bio
Aug 11, 2026
Reiterated: Buy
Price Target: $8
Current: $1.54
Upside: +419.48%
Aug 7, 2026
Rated: Buy
Price Target: $98 → $97
Current: $54.80
Upside: +77.02%
Aug 7, 2026
Reiterated: Buy
Price Target: $18
Current: $11.00
Upside: +63.64%
Aug 7, 2026
Reiterated: Buy
Price Target: $54
Current: $30.47
Upside: +77.22%
Aug 7, 2026
Reiterated: Buy
Price Target: $326
Current: $301.81
Upside: +8.01%
Aug 7, 2026
Reiterated: Buy
Price Target: $24 → $25
Current: $13.19
Upside: +89.54%
Aug 6, 2026
Reiterated: Buy
Price Target: $50 → $60
Current: $36.83
Upside: +62.91%
Jun 22, 2026
Rated: Hold
Price Target: n/a
Current: $1.73
Upside: -
Jun 22, 2026
Rated: Hold
Price Target: n/a
Current: $3.77
Upside: -
Jun 15, 2026
Reiterated: Buy
Price Target: $14
Current: $2.98
Upside: +369.80%
May 20, 2026
Reiterated: Buy
Price Target: $25 → $28
Current: $2.76
Upside: +916.33%
May 15, 2026
Reiterated: Buy
Price Target: $10
Current: $1.27
Upside: +687.40%
Apr 13, 2026
Rated: Hold
Price Target: n/a
Current: $18.66
Upside: -
Feb 27, 2026
Reiterated: Buy
Price Target: $35 → $21
Current: $4.76
Upside: +341.18%
Feb 12, 2026
Reiterated: Buy
Price Target: $25
Current: $2.46
Upside: +916.26%
Feb 10, 2026
Rated: Hold
Price Target: n/a
Current: $27.66
Upside: -
Nov 14, 2025
Reiterated: Buy
Price Target: $2,000
Current: $31.73
Upside: +6,203.18%
Nov 7, 2025
Reiterated: Buy
Price Target: $18
Current: $10.48
Upside: +71.76%
Nov 4, 2025
Downgraded: Hold
Price Target: n/a
Current: $90.78
Upside: -
Sep 29, 2025
Reiterated: Buy
Price Target: $35
Current: $13.65
Upside: n/a
Sep 3, 2025
Initiated Coverage: Buy
Price Target: $80
Current: $23.33
Upside: n/a
Aug 4, 2025
Upgraded: Buy
Price Target: $490
Current: $232.68
Upside: n/a
Sep 16, 2024
Reiterated: Buy
Price Target: $25
Current: $1.10
Upside: n/a
May 14, 2024
Reiterated: Buy
Price Target: $106
Current: $62.91
Upside: n/a
Mar 28, 2024
Initiated Coverage: Buy
Price Target: n/a
Current: $1.38
Upside: n/a
Dec 18, 2023
Reiterated: Buy
Price Target: n/a
Current: $2.91
Upside: n/a
Nov 13, 2023
Reiterated: Buy
Price Target: $11
Current: $0.765
Upside: n/a
Jul 10, 2023
Reiterated: Buy
Price Target: n/a
Current: $2.08
Upside: n/a
Oct 4, 2022
Downgraded: Hold
Price Target: n/a
Current: $3.86
Upside: n/a
May 26, 2022
Reiterated: Buy
Price Target: $60
Current: $0.11
Upside: n/a
Mar 21, 2022
Reiterated: Buy
Price Target: $70 → $200
Current: $0.000001
Upside: n/a
Nov 16, 2021
Reiterated: Hold
Price Target: n/a
Current: $5.38
Upside: n/a
Jun 4, 2021
Initiated Coverage: Buy
Price Target: $8
Current: $0.001
Upside: n/a
Jun 2, 2021
Rated: Buy
Price Target: $12
Current: $0.4298
Upside: n/a
May 18, 2021
Rated: Buy
Price Target: $7
Current: $1.14
Upside: n/a
May 7, 2021
Initiated Coverage: Buy
Price Target: $42
Current: $1.38
Upside: n/a
May 6, 2021
Reiterated: Hold
Price Target: n/a
Current: $0.012
Upside: n/a
Dec 31, 2020
Rated: Hold
Price Target: n/a
Current: $10.36
Upside: n/a
Dec 31, 2020
Rated: Hold
Price Target: n/a
Current: $12.03
Upside: n/a
Dec 31, 2020
Rated: Hold
Price Target: n/a
Current: $0.5989
Upside: n/a
Sep 11, 2020
Rated: Hold
Price Target: n/a
Current: $0.0079
Upside: n/a
May 10, 2019
Reiterated: Buy
Price Target: $7
Current: $1.27
Upside: n/a
May 9, 2019
Rated: Hold
Price Target: n/a
Current: $1.08
Upside: n/a
Apr 3, 2019
Reiterated: Buy
Price Target: $8
Current: $4.97
Upside: n/a